(Q32065989)

6 July 2017

title

Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain (English)

1 reference

6 July 2017

0 references

0 references

Neighbors DM

1

1 reference

6 July 2017

Bell TJ

series ordinal

2

1 reference

6 July 2017

Wilson J

series ordinal

3

1 reference

6 July 2017

Dodd SL

series ordinal

4

1 reference

6 July 2017

publication date

1 February 2001

1 reference

Journal of Pain and Symptom Management

6 July 2017

published in

1 reference

6 July 2017

volume

21

1 reference

6 July 2017

issue

2

1 reference

6 July 2017

page(s)

129-143

1 reference

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

New approaches to pain control in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Guidelines for the clinical use of transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Withdrawal with transdermal fentanyl.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Transdermal fentanyl: seeding trial in patients with chronic cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Management of cancer pain with transdermal fentanyl: phase IV trial, University of Iowa

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Transdermal fentanyl: clinical trial at the University of Colorado Health Sciences Center

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Duragesic (transdermal fentanyl) in hospice care.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Long-term oral opioid therapy in patients with chronic nonmalignant pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

The costs of managing severe cancer pain and potential savings from transdermal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Controlled-release oxycodone and morphine in cancer related pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900247-5

7 January 2021

10.1016/S0885-3924(00)00247-5

Identifiers

DOI

1 reference

release_t6yr2xoljbcwjf3qbr5incjaru

6 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t6yr2xoljbcwjf3qbr5incjaru

24 November 2022

mapped directly with Wikidata item

1 reference